CN Patent

CN110054617A — 三嗪类化合物、其制备方法及用途

Assigned to Nanjing Sanhome Pharmaceutical Co Ltd · Expires 2019-07-26 · 7y expired

What this patent protects

本发明属于医药化学领域，具体涉及三嗪类化合物、其制备方法及其作为参比对照品用于(S)‑3‑(三氟甲基)‑1‑(4‑(6‑(三氟甲基)吡啶‑2‑基)‑6‑(2‑(三氟甲基)吡啶‑4‑氨基)‑1,3,5‑三嗪‑2‑基)吡咯烷‑3‑醇甲磺酸盐原料药质量研究中相关杂质定性和/或定量分析的用途。

USPTO Abstract

本发明属于医药化学领域，具体涉及三嗪类化合物、其制备方法及其作为参比对照品用于(S)‑3‑(三氟甲基)‑1‑(4‑(6‑(三氟甲基)吡啶‑2‑基)‑6‑(2‑(三氟甲基)吡啶‑4‑氨基)‑1,3,5‑三嗪‑2‑基)吡咯烷‑3‑醇甲磺酸盐原料药质量研究中相关杂质定性和/或定量分析的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN110054617A
Jurisdiction
CN
Classification
—
Expires
2019-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Sanhome Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.